Insmed Incorporated · 3 hours ago
Vice President, Product Development - CMC, Small Molecules
Insmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. They are seeking a highly experienced Vice President of Product Development to lead Chemistry, Manufacturing, and Controls (CMC) activities for their small molecule pipeline, ensuring compliance with regulatory standards and overseeing drug development initiatives.
BiotechnologyMedicalPharmaceutical
Responsibilities
Provide strategic leadership by defining and executing the CMC strategy for all small molecule programs throughout their lifecycle, from preclinical development through commercialization
Serve as a key member of the Technical Operations leadership team and contribute significantly to overall product development strategy
Lead both drug substance (API) and drug product development initiatives, including formulation development, process chemistry, and scale-up operations
Oversee analytical method development and validations and have experience in combination devices
Ensure manufacturing readiness for both clinical and commercial supply chains
Support global CMC regulatory strategies that align with clinical and commercial objectives
Author, review, and approve CMC sections of regulatory submissions including INDs, NDAs/MAAs, and other required documentation
Ensure compliance with ICH, FDA, EMA, PMDA and other international regulatory guidelines
Build and lead a high-performing CMC team while managing relationships with external manufacturing partners and CDMOs to ensure reliable clinical supply and maintain quality standards
Partner with Discovery, Clinical Development, Quality, Regulatory Affairs, Operations, and Commercial teams to ensure seamless program advancement
Provide technical expertise and due diligence support for business development opportunities
Qualification
Required
Ph.D. or advanced degree in Chemistry, Pharmaceutical Sciences, Chemical Engineering, or related field
15+ years of progressive experience in CMC development for small molecule pharmaceuticals, with at least 7 years in senior leadership
Proven track record in advancing programs from preclinical to commercial launch
Deep knowledge of small molecule process chemistry, formulation, and analytical development
Demonstrated success in regulatory submissions and global CMC regulatory requirements
Experience managing external partners (CMOs/CDMOs)
Strong leadership, strategic thinking, and communication skills
Benefits
Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back
Company
Insmed Incorporated
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$4.56BKey Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-01-13
2026-01-11
Company data provided by crunchbase